Why shares of Brickell Biotech Inc. (BBI) stock are soaring in after-market trading?
Brickell Biotech, Inc. (BBI), a clinical-stage pharmaceutical company specializing to produce innovative and differentiated prescription therapeutics to treat impairing skin diseases, announced financial results for the first quarter completed on March 31, 2021. BBI stock surged adjacent to the news. At last check in after-market trading, shares of Brickell Biotech Inc. (BBI) were up 8.14% […]
